131 related articles for article (PubMed ID: 16027527)
1. Tumor-targeted and activated bioconjugates for improved camptothecin delivery.
Paranjpe PV; Stein S; Sinko PJ
Anticancer Drugs; 2005 Aug; 16(7):763-75. PubMed ID: 16027527
[TBL] [Abstract][Full Text] [Related]
2. Synergistic antitumor efficacy of redox and pH dually responsive micelleplexes for co-delivery of camptothecin and genes.
Chen M; Zhang Y; Chen Z; Xie S; Luo X; Li X
Acta Biomater; 2017 Feb; 49():444-455. PubMed ID: 27940163
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of camptothecin and polymer-conjugated camptothecin in tumor spheroids and solid tumors.
Ying V; Haverstick K; Page RL; Saltzman WM
J Biomater Sci Polym Ed; 2007; 18(10):1283-99. PubMed ID: 17939886
[TBL] [Abstract][Full Text] [Related]
4. Targeted nanoparticles assembled via complexation of boronic-acid-containing targeting moieties to diol-containing polymers.
Han H; Davis ME
Bioconjug Chem; 2013 Apr; 24(4):669-77. PubMed ID: 23461746
[TBL] [Abstract][Full Text] [Related]
5. Tumor-targeted bioconjugate based delivery of camptothecin: design, synthesis and in vitro evaluation.
Paranjpe PV; Chen Y; Kholodovych V; Welsh W; Stein S; Sinko PJ
J Control Release; 2004 Nov; 100(2):275-92. PubMed ID: 15544875
[TBL] [Abstract][Full Text] [Related]
6. Preparation of camptothecin-loaded targeting nanoparticles and their antitumor effects on hepatocellular carcinoma cell line H22.
Yang A; Liu Z; Yan B; Zhou M; Xiong X
Drug Deliv; 2016 Jun; 23(5):1699-706. PubMed ID: 25148540
[TBL] [Abstract][Full Text] [Related]
7. Targeted tumor theranostics using folate-conjugated and camptothecin-loaded acoustic nanodroplets in a mouse xenograft model.
Chen WT; Kang ST; Lin JL; Wang CH; Chen RC; Yeh CK
Biomaterials; 2015; 53():699-708. PubMed ID: 25890765
[TBL] [Abstract][Full Text] [Related]
8. Camptothecin delivery systems: the utility of amino acid spacers for the conjugation of camptothecin with polyethylene glycol to create prodrugs.
Conover CD; Greenwald RB; Pendri A; Shum KL
Anticancer Drug Des; 1999 Dec; 14(6):499-506. PubMed ID: 10834271
[TBL] [Abstract][Full Text] [Related]
9. Folate-decorated and reduction-sensitive micelles assembled from amphiphilic polymer-camptothecin conjugates for intracellular drug delivery.
Liu C; Yuan J; Luo X; Chen M; Chen Z; Zhao Y; Li X
Mol Pharm; 2014 Nov; 11(11):4258-69. PubMed ID: 25238329
[TBL] [Abstract][Full Text] [Related]
10. Enzyme sensitive, surface engineered nanoparticles for enhanced delivery of camptothecin.
Yu H; Chen J; Liu S; Lu Q; He J; Zhou Z; Hu Y
J Control Release; 2015 Oct; 216():111-20. PubMed ID: 26282096
[TBL] [Abstract][Full Text] [Related]
11. Novel delivery of SN38 markedly inhibits tumor growth in xenografts, including a camptothecin-11-refractory model.
Sapra P; Zhao H; Mehlig M; Malaby J; Kraft P; Longley C; Greenberger LM; Horak ID
Clin Cancer Res; 2008 Mar; 14(6):1888-96. PubMed ID: 18347192
[TBL] [Abstract][Full Text] [Related]
12. Development of pH-Sensitive Cationic PEGylated Solid Lipid Nanoparticles for Selective Cancer-Targeted Therapy.
Chuang CH; Wu PC; Tsai TH; Fang YP; Tsai YH; Cheng TC; Huang CC; Huang MY; Chen FM; Hsieh YC; Lin WW; Tsai MJ; Cheng TL
J Biomed Nanotechnol; 2017 Feb; 13(2):192-03. PubMed ID: 29377649
[TBL] [Abstract][Full Text] [Related]
13. Albumin-binding prodrugs of camptothecin and doxorubicin with an Ala-Leu-Ala-Leu-linker that are cleaved by cathepsin B: synthesis and antitumor efficacy.
Schmid B; Chung DE; Warnecke A; Fichtner I; Kratz F
Bioconjug Chem; 2007; 18(3):702-16. PubMed ID: 17378599
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of poly(ethylene glycol)-camptothecin conjugate: the inhibition of tumor growth in vivo.
Yu D; Peng P; Dharap SS; Wang Y; Mehlig M; Chandna P; Zhao H; Filpula D; Yang K; Borowski V; Borchard G; Zhang Z; Minko T
J Control Release; 2005 Dec; 110(1):90-102. PubMed ID: 16271793
[TBL] [Abstract][Full Text] [Related]
15. Folic acid-conjugated chitosan oligosaccharide-magnetic halloysite nanotubes as a delivery system for camptothecin.
Dramou P; Fizir M; Taleb A; Itatahine A; Dahiru NS; Mehdi YA; Wei L; Zhang J; He H
Carbohydr Polym; 2018 Oct; 197():117-127. PubMed ID: 30007596
[TBL] [Abstract][Full Text] [Related]
16. Improved tumor targeting and antitumor activity of camptothecin loaded solid lipid nanoparticles by preinjection of blank solid lipid nanoparticles.
Jang DJ; Moon C; Oh E
Biomed Pharmacother; 2016 May; 80():162-172. PubMed ID: 27133053
[TBL] [Abstract][Full Text] [Related]
17. Antitumor activity of beta-cyclodextrin polymer-camptothecin conjugates.
Cheng J; Khin KT; Davis ME
Mol Pharm; 2004; 1(3):183-93. PubMed ID: 15981921
[TBL] [Abstract][Full Text] [Related]
18. Enhanced anti-hepatocarcinoma efficacy by GLUT1 targeting and cellular microenvironment-responsive PAMAM-camptothecin conjugate.
Ma P; Sun Y; Chen J; Li H; Zhu H; Gao X; Bi X; Zhang Y
Drug Deliv; 2018 Nov; 25(1):153-165. PubMed ID: 29282992
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and preliminary in vivo tests of new poly(ethylene glycol) conjugates of the antitumor agent 10-amino-7-ethylcamptothecin.
Guiotto A; Canevari M; Orsolini P; Lavanchy O; Deuschel C; Kaneda N; Kurita A; Matsuzaki T; Yaegashi T; Sawada S; Veronese FM
J Med Chem; 2004 Feb; 47(5):1280-9. PubMed ID: 14971908
[TBL] [Abstract][Full Text] [Related]
20. In vitro cytotoxicity and in vivo distribution after direct delivery of PEG-camptothecin conjugates to the rat brain.
Fleming AB; Haverstick K; Saltzman WM
Bioconjug Chem; 2004; 15(6):1364-75. PubMed ID: 15546204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
